IL18 and neoplasm: Moreover, Song et al. (2025) uncovered a novel subset of cancer-promoting regulatory T (Treg) cells expressing IL-1β and IL-18, which interact with MRC1+FOLR2+ tumor-associated macrophages at the tumor-normal interface, thereby reinforcing an immunosuppressive TME that fosters tumor progression [50].